Ezra raises $21 million

Ezra AI, a startup offering MRI imaging for early cancer detection, has raised $21 million in a round co-led by Healthier Capital and FirstMark Capital, with participation from Allianz Life Ventures, and others.

Founded in 2018 and based in New York, the startup utilizes medical imaging and artificial intelligence to provide individuals with a full body cancer screening service that is “fast, accurate, and affordable.” Ezra claims that it stands apart by leveraging proprietary AIs across all three key components of the cancer screening process: imaging, analysis, and reporting.

The startup partners with imaging facilities and offers three types of scans with the most comprehensive one costing $2,500. Within two to three years, Ezra will introduce “the world’s first” 15-minute full body MRI, priced at around $500.

The funding will be used to accelerate Ezra’s expansion to 20 cities and 50 locations across North America in 2024.

“Five years ago, Ezra pioneered the full body MRI space by being the first company in the US to offer fast, accurate, affordable, AI-powered full body MRI scans. We have since scanned thousands of people and have helped countless individuals identify cancer and over 500 other types of diseases early. This year, 10 million people will receive late-stage cancer diagnoses, with survival chances below 20%. At Ezra, we aim to detect cancer early for these 10 million people, improving their chance of getting cured. I’m thrilled to join forces with Healthier Capital and Amir Dan Rubin to further our goal of making cancer screening more affordable and accessible.” – Emi Gal, Founder and CEO of Ezra.

“At Healthier Capital we are excited to see how the Ezra team, led by Founder & CEO Emi Gal, is leveraging AI in imaging to significantly increase affordability, access and outcomes.” – Amir Dan Rubin, CEO and Founding Managing Partner at Healthier Capital.

“As a long-standing board member and investor in Ezra, I have witnessed first-hand the remarkable progress and impact this company has made in the field of early cancer detection. Ezra’s recent advancements in AI-powered full body MRI scans represent a significant leap in making cancer screening more accessible and affordable, and I am incredibly proud to be part of this mission to detect cancer early for everyone.” – Rick Heitzmann, Co-founder & Partner at FirstMark Capital.